GTR Test Accession:
Help
GTR000500606.7
CAP
Last updated in GTR:
2020-08-10
View version history
GTR000500606.7,
last updated:
2020-08-10
GTR000500606.6,
last updated:
2020-08-06
GTR000500606.5,
last updated:
2020-08-04
GTR000500606.4,
last updated:
2019-08-14
GTR000500606.3,
last updated:
2019-06-26
GTR000500606.2,
last updated:
2016-03-14
GTR000500606.1,
registered in GTR:
2014-02-19
Last annual review date for the lab: 2025-07-01
LinkOut
At a Glance
Methods (2):
Help
Molecular Genetics - Deletion/duplication analysis: MS-MLPA; ...
Target population: Help
Not provided
Clinical validity:
Help
Deletion and methylation analysis of the critical region in chromosome …
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Test short name:
Help
AS
Specimen Source:
Help
- Peripheral (whole) blood
Who can order: Help
- Licensed Physician
Test Order Code:
Help
2415
Lab contact:
Help
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
How to Order,
Test strategy,
Test development
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Chromosomal regions/Mitochondria
Help
Total chromosomal regions/mitochondria: 1
Chromosomal region/Mitochondrion | Associated condition |
---|
Methodology
Total methods: 2
Method Category
Help
Test method
Help
Instrument *
Deletion/duplication analysis
MS-MLPA
Methylation analysis
MS-MLPA
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Clinical validity:
Help
Deletion and methylation analysis of the critical region in chromosome 15 accounts for approx. 75% of alterations in Angelman syndrome.
Clinical utility:
Help
Establish or confirm diagnosis
View citations (1)
- Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Bittel DC, et al. Genet Test. 2007;11(4):467-75. doi:10.1089/gte.2007.0061. PMID: 18294067.
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
Decline to answer.
Decline to answer.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Decline to answer.
Decline to answer.
Recommended fields not provided:
Target population,
What is the protocol for interpreting a variation as a VUS?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Deletion and methylation analysis of the critical region in chromosome 15 accounts for approx. 75% of alterations in Angelman syndrome. For validation, 17 CAP samples and 2 patients with a cytogenetic report were analyzed.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Clinical resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.